Additionally, SLC13A3-mediated itaconate uptake by tumor cells directly alkylates PD-L1 at cysteine 272 to promote PD-L1 stabilization leading to tumor immune evasion [155]. The gene discussed is SLC13A3; the disease is neoplasm.